Lipella Pharmaceuticals
Stock Forecast, Prediction & Price Target
Lipella Pharmaceuticals Financial Estimates
Lipella Pharmaceuticals Revenue Estimates
Lipella Pharmaceuticals EBITDA Estimates
Lipella Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $259.34K N/A | $184.15K -28.99% | $449.61K 144.15% | Avg: $535.16K Low: $535.16K High: $535.16K avg. 19.02% | Avg: $583.86K Low: $583.86K High: $583.86K avg. 9.09% | Avg: $636.98K Low: $636.98K High: $636.98K avg. 9.09% | Avg: $35.16M Low: $35.16M High: $35.16M avg. 5419.72% |
Net Income
% change YoY
| $-1.87M N/A | $-2.59M -38.66% | $-4.61M -77.92% | Avg: $-1.68M Low: $-1.68M High: $-1.68M avg. 63.60% | Avg: $-1.86M Low: $-1.86M High: $-1.86M avg. -10.71% | Avg: $-1.92M Low: $-1.92M High: $-1.92M avg. -3.22% | Avg: $1.86M Low: $1.86M High: $1.86M avg. 196.87% |
EBITDA
% change YoY
| $-1.85M N/A | $-2.58M -39.24% | $-4.60M -77.98% | Avg: $-335.36K Low: $-335.36K High: $-335.36K avg. 92.71% | Avg: $-365.87K Low: $-365.87K High: $-365.87K avg. -9.09% | Avg: $-399.16K Low: $-399.16K High: $-399.16K avg. -9.09% | Avg: $-22.03M Low: $-22.03M High: $-22.03M avg. -5419.72% |
EPS
% change YoY
| -$0.33 N/A | -$0.45 -36.36% | -$0.77 -71.11% | Avg: -$0.28 Low: -$0.28 High: -$0.28 avg. 63.63% | Avg: -$0.31 Low: -$0.31 High: -$0.31 avg. -10.71% | Avg: -$0.32 Low: -$0.32 High: -$0.32 avg. -3.22% | Avg: $0.31 Low: $0.31 High: $0.31 avg. 196.87% |
Operating Expenses
% change YoY
| $2.17M N/A | $2.77M 27.52% | $2.15M -22.24% | Avg: $955.81K Low: $955.81K High: $955.81K avg. -55.68% | Avg: $1.04M Low: $1.04M High: $1.04M avg. 9.09% | Avg: $1.13M Low: $1.13M High: $1.13M avg. 9.09% | Avg: $62.79M Low: $62.79M High: $62.79M avg. 5419.72% |
FAQ
What is Lipella Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 61.63% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -1.68M, average is -1.68M and high is -1.68M.
What is Lipella Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1364.23% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $535.16K, average is $535.16K and high is $535.16K.
What is Lipella Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 61.64% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.28, average is -$0.28 and high is $-0.28.
What is the best performing analyst?
In the last twelve months analysts have been covering Lipella Pharmaceuticals stock. The most successful analyst is Jason McCarthy.